Concepedia

Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study

Kiren Kresa-Reahl, Pavle Repovic, Derrick Robertson, Macaulay Okwuokenye, Leslie Meltzer, Jason P. Mendoza

Clinical Therapeutics · 2018 · 35 citations · 17 references

DOI

Concepts

References

17

The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

Margaret C. Reilly, Arthur S. Zbrozek, Ellen Dukes · PharmacoEconomics · 1993 · 3.1K citations

, , +13

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

Ralf Gold, Ludwig Kappos, Douglas L. Arnold et al. · New England Journal of Medicine · 2012 · 1.7K citations · Full text

, , +17

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox, David H. Miller, J. Theodore Phillips et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text

, , +6

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.

Mark J. Atkinson, Anusha Sinha, Steven Hass et al. · Health and Quality of Life Outcomes · 2004 · 996 citations · Full text

, , +16

Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting

Carlos De las Cuevas, Wenceslao Peñate · International Journal of Clinical and Health Psychology · 2014 · 122 citations · Full text

, , +17